Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Stock Traders Daily
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Pechala's Reports
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Conmed Corp Issues Q4 2012 Guidance In Line With Analysts' Estimates; Lowers High End Of Prior FY 2012 Revenue Guidance; Narrows FY 2012 EPS Guidance To A Range In Line With Analysts' Estimates


Thursday, 25 Oct 2012 07:00am EDT 

Conmed Corp announced that for the fourth quarter of 2012, it expects sales and earnings consistent with previous guidance. It anticipates fourth quarter 2012 sales to approximate $199-$204 million and adjusted earnings per share (EPS) to be in the range of $0.48-$0.52. Based on this outlook for the fourth quarter, the Company is narrowing guidance for fiscal 2012 although it remains within the previously provided wider ranges and expects fiscal 2012 sales of $765-$770 million and adjusted diluted EPS of $1.76 - $1.80. According to I/B/E/S Estimates, analysts were expecting the Company to report revenue of $199 million and EPS of $0.51 for the fourth quarter of 2012; revenue of $766 million and EPS of $1.76 for fiscal 2012. 

Company Quote

47.65
-0.56 -1.16%
17 Apr 2014